Findings from our study provide further evidence that β2AR agonists are associated with reduced risk of PD, which is unlikely explained solely by smoking due to the following reasons: One would expect attenuation in this association after adjustment for education and comorbidity as factors strongly associated with smoking, and after the exclusion of COPD patients. The gene discussed is ADRB2; the disease is Parkinson disease.